NYSEARCA:THNR Amplify Weight Loss Drug & Treatment ETF (THNR) Price, Holdings, & News $23.00 +0.13 (+0.57%) (As of 11/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatings About Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get THNR alerts:Sign Up Key Stats Today's Range$22.99▼$23.1650-Day Range$22.71▼$27.7052-Week Range$22.57▼$28.19Volume3,981 shsAverage Volume4,738 shsMarket CapitalizationN/AAssets Under Management$4.17 millionDividend YieldN/ANet Expense Ratio0.59%Aggregate RatingModerate Buy ETF OverviewRead More… Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Amplify Weight Loss Drug & Treatment ETF ExpensesTypeTHNRTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.59%0.57%0.55%0.51%0.52%Other Expenses0.00%0.57%0.49%0.57%0.53%Total Expense0.59%0.72%0.71%0.73%0.71%Fee Waiver0.00%-0.73%-0.52%-0.67%-0.57%Net Expense0.59%0.60%0.61%0.58%0.59% Receive THNR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address THNR ETF News HeadlinesWhy Investors Haven't Feasted on Two New Weight-Loss ETFsJune 24, 2024 | investopedia.comSee More Headlines THNR ETF - Frequently Asked Questions How have THNR shares performed this year? Amplify Weight Loss Drug & Treatment ETF's stock was trading at $25.40 at the start of the year. Since then, THNR shares have decreased by 9.4% and is now trading at $23.00. View the best growth stocks for 2024 here. Who are Amplify Weight Loss Drug & Treatment ETF's major shareholders? Amplify Weight Loss Drug & Treatment ETF's top institutional shareholders include Jane Street Group LLC and Harbour Investments Inc.. How do I buy shares of Amplify Weight Loss Drug & Treatment ETF? Shares of THNR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Amplify Weight Loss Drug & Treatment ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Amplify Weight Loss Drug & Treatment ETF investors own include Archer Aviation (ACHR), Advanced Micro Devices (AMD), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Lockheed Martin (LMT), NICE (NICE) and Intellia Therapeutics (NTLA). Fund Details IssuerAmplify Fund NameAmplify Weight Loss Drug & Treatment ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:THNR Inception Date5/21/2024 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionGlobal Number of Holdings30 Fund Statistics Assets Under Management$4.17 million Average Daily Volume$0.00 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorAmplify Investments LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerGTS Options OptionableN/A Short Interest200 shs Miscellaneous Outstanding SharesN/ABetaN/A Creation Unit10,000 Creation Fee$300.00 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Top 10 THNR HoldingsEli Lilly and Company (NYSE:LLY)Holding Weight: 14.69%Novo Nordisk A/S (NYSE:NVO)Holding Weight: 13.17%Roche Holding AGHolding Weight: 5.38%Amgen (NASDAQ:AMGN)Holding Weight: 5.36%Chugai Pharmaceutical Co., Ltd.Holding Weight: 5.27%Pfizer (NYSE:PFE)Holding Weight: 4.95%Thermo Fisher Scientific (NYSE:TMO)Holding Weight: 4.90%Merck & Co., Inc. (NYSE:MRK)Holding Weight: 4.81%FUJIFILM Holdings CorporationHolding Weight: 4.53%AstraZeneca (NASDAQ:AZN)Holding Weight: 4.51%Full Holdings DetailsTHNR Sector ExposureTHNR Industry Exposure This page (NYSEARCA:THNR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
